Clinical Trials Browser

Observational × Registries × Clear all

NCT03413982 2026-03-10

GUB-BCR-001

Urinary Bladder Neoplasms

NCT04511806 2025-10-29

CCPS

Neoplasms

NCT04376229 2025-07-01

Proton Radiation Therapy Registry

Neoplasms, Second Primary

NCT05174338 2023-09-06

CARS

Immunoglobulin Light-chain Amyloidosis

NCT03221075 2023-05-12

CLARITY

Invasive Aspergillosis

NCT05845801 2023-05-06

PanC-YOUNG

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT04045236 2023-03-23

FUCORE

Gastrointestinal

Non Metastatic Rectal Cancer

NCT02070328 2023-02-08

Registry

Neoplasms

NCT03553732 2022-08-04

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

Chronic Disease, Prostatic Neoplasms

NCT03546322 2022-07-01

Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers

Chronic Disease, Head and Neck Neoplasms

NCT03886753 2020-07-30

Ilera

Classical hematology

Autism Spectrum Disorder, Acquired Immunodeficiency Syndrome, Anemia, Sickle Cell, Epilepsy, Glaucoma, Huntington Disease, Multiple Sclerosis, Muscle Spasticity, Neoplasms, Pain, Intractable, Parkinson Disease, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Dyskinesias

NCT00850941 2019-05-15

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

Adenocarcinoma, Prostatic Neoplasms

NCT01842555 2018-08-24

PDT Registry

Lung Neoplasms

NCT02865330 2018-02-12

Spanish Urological Association Registry of Patients on Active Surveillance

Prostatic Neoplasms

NCT02454595 2017-09-05

Registry to Measure the Impact of Adding Genomic Testing

Prostatic Neoplasms

NCT02613637 2017-02-24

Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project

Lung Neoplasms

NCT01813825 2013-03-19

A Single Site Prospective, Non-randomized Study of Partial Breast Intracavitary Brachytherapy Devices to Evaluate Local Tumor Control, Cosmetic Outcome and Toxicities.

This Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting.